FinanceAsia: Deals Ramp Up in Asia’s Healthcare Space with Cancer Focus

There have been significant advancements in the Asian cancer treatment sector, attracting increased attention from investors. It is projected that the Asian oncology drugs market will reach US$76.66 billion by 2028. Moreover, the number of cancer cases in Asia is expected to rise significantly, with over 35 million new cases globally by 2050.

Garri Zmudze discussed the cancer treatment sector in Asia, its landscape, and its potential with Andrew Tjaardstra from Finance Asia during his recent visit to Hong Kong.

For further information, you can read Andrew’s recent article on this topic, including Garri’s commentary, here.